Erding Hu
GlaxoSmithKline (United States) · 68 works · 12,491 citations · h-index 37
Top works
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
- PPARγ2 Regulates Adipose Expression of the Phosphoenolpyruvate Carboxykinase Gene
- Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR7 and RXRa
- Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ
- Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha
- Targeted disruption of the c‐fos gene demonstrates c‐fos‐dependent and ‐independent pathways for gene expression stimulated by growth factors or oncogenes.
- Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor
- Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
- Adipocyte differentiation: a transcriptional regulatory cascade
- Peroxisome proliferator-activated receptor gamma and the control of adipogenesis
- Casein kinase II from Caenorhabditis elegans. Properties and developmental regulation of the enzyme; cloning and sequence analyses of cDNA and the gene for the catalytic subunit.
- Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges
- PPARγ and the control of adipogenesis
- Cloning, Expression, and Initial Characterization of a Novel Cytokine-like Gene Family
- Expression of wild-type and mutated forms of the catalytic (alpha) subunit of Caenorhabditis elegans casein kinase II in Escherichia coli
- Casein kinase II from Caenorhabditis elegans. Cloning, characterization, and developmental regulation of the gene encoding the beta subunit.
- Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors
- Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities